<i>Cracked Open</i>: New Book Looks at Fertility and Reproductive Technology
By Rachel,
Our Bodies Our Blog
| 04. 30. 2013
Our Bodies Ourselves board member
Miriam Zoll has a new book coming out on May 1,
Cracked Open: Liberty, Fertility and the Pursuit of High Tech Babies.
Zoll tells her own story of infertility and IVF treatments, and shares what she learned along the way about assisted reproductive technologies.
From the book description:
When things don’t progress as she had hoped, she and her husband enter a science-fiction world of medical seduction, capitalist conception and bioethical quagmires. Desperate to conceive, they turn to unproven treatments and procedures only to learn that the odds of becoming parents through reproductive medicine are far less than they and their generation had been led to believe.
OBOS Co-Founder and Executive Director Judy Norsigian contributed to the foreword with Michele Goodwin, a professor of law at the University of Minnesota. Learn more about Zoll and “Cracked Open” as she
shares her story on the My Fertility Choices site.
Zoll is also collecting stories on infertility and reproductive technology
via her website. Requests to have her come speak can also
be made online.
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...